Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 23, 2020

Medical holographic company RealView Imaging obtains $10m

Israel-based medical holography company RealView Imaging has closed a $10m Series C financing round.

Israel-based medical holography company RealView Imaging has closed a $10m Series C financing round.

The round was joined by new investors OurCrowd and Judith and Kobi Richter, along with the company’s existing shareholders, including Dr Shimon Eckhouse, Zohar Gilon and Uzia Galil and other technology and medical Israeli entrepreneurs.

Medinol founder and chairman Dr Kobi Richter and Cardiology Institute at Sheba Medical Center former director Prof Michael Eldar secured seats on the company’s board, following the closing of Series C round.

RealView is currently developing holographic augmented reality (AR) medical system called HOLOSCOPE-x to facilitate precise minimally invasive interventional procedures. The system is designed to project 3D holographic images inside the patient’s body by creating 3D volumetric holograms from medical imaging data.

Dr Shimon Eckhouse said: “We are now focused on the commercialisation of the HOLOSCOPE-i system, initially in North America and in Europe.

“By incorporating medical holography into routine clinical workflow, we expect to revolutionise the way clinicians engage with 3D medical imaging.”

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

The HOLOSCOPE-i system is expected to help physicians view and directly interact with hyper-realistic 3D holograms that float in free space at hands reach during interventional procedures. Its advanced 3D interactive visualisation tools empower imaging-based minimally invasive medical interventions.

Dr Kobi Richter said: “RealView has created a unique solution that will address fundamental usability requirements and a wide range of clinical needs for advanced imaging.

“Given the company’s broad IP portfolio and technology maturity, I believe RealView can significantly impact the growing field of structural heart interventions, as well as additional future clinical fields such as electrophysiology and interventional oncology procedures.”

In 2017, RealView integrated the Intel RealSense SR300-Series camera into the HOLOSCOPE-i system.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU